What plans does the Secretary of State have to secure value for money from the additional funds allocated to the NHS for 2022-23?

image_pdfimage_print

The Department of Health and Social Care has provided the following answer to your written parliamentary question (119393):

Question:

Rt Hon Sir John Redwood MP (Wokingham) (Con): To ask the Secretary of State for Health and Social Care, what plans he has to secure value for money from the additional funds allocated to the NHS for 2022-23. (119393)

Tabled on: 07 February 2022

Answer:
Edward Argar, Minister of State:

The new Health and Social Care Levy provides £23.3 billion for the National Health Service over the Spending Review period. We will ensure that this investment is provided for frontline care in England, increasing efficiencies and using reforms to improve productivity. This will include prioritising diagnosis and treatment, transforming the delivery of elective care and providing better information and support to patients.

The answer was submitted on 15 Mar 2022 at 09:50.

I asked this question for a variety of reasons. I think it will prove difficult to switch the money from this tax from the NHS to social care over the course of the next three years as planned. I am concerned that it will lead some people to think £12bn extra on the huge NHS budget or £12 bn in total for social care will handle the needs of each service, when the current totals on public health and government financed social care in the UK is already at £230bn. I am concerned about how the money will be spent, wanting to see more detailed plans of how the money is spent on the extra nurses, doctors, medicines and procedures that are needed to clear the backlists.

There are savings to be banked from the end of the pandemic. The large costs in setting up and rolling out new vaccines and the test and trace system will be behind us, and the high costs of the early intensive care of covid patients will be much reduced now the vaccines cut the numbers and reduce the severity of the disease for most patients. I am also trying to find out how costs will change following the current reorganisation of management structures where presumably efficiency was part of the original plan behind yet another reorganisation.

Leave a Reply

Your email address will not be published.